NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ACOR - Acorda Therapeutics Inc

Acorda Therapeutics, Inc. (Acorda), incorporated in 1995, is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system. Ampyra (dalfampridine) is an extended release tablet formulation of dalfampridine (","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ACORhart

Acorda Therapeutics Inc News


Our Take: Our Take: Stock Analysts' New Coverage for May, 18th (ACOR, ANGI ...
The Mumbai Times - May 19, 2012
Merck & Co Inc (NYSE:MRK) shares were trading at $37.82 while reporting down 0.55% from yesterdays close. The 16 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 42.50, with a high estimate of 46.00 and a low ...

Goldman Sachs Initiates Coverage on Acorda Therapeutics (ACOR)
Junction Report - May 18, 2012
Analysts at Goldman Sachs (NYSE: GS) initiated coverage on shares of Acorda Therapeutics (NASDAQ: ACOR) in a research report issued to clients and investors on Friday.

Health Care Sector Wrap
Fox Business - May 18, 2012
The S&P 500 lost 0.9% while the Health Care sector (XLV) showed little movement during trading today. While being down today, the ETF, as a proxy for sector performance, tracked closer to the overall market today than over the past month.

Breaking News: New Stock Coverage: Sun Shines on Hawaiian Holdings
The Mumbai Times - May 18, 2012
The 22 analysts offering 12-month price forecasts for Corning Inc have a median target of 16.00, with a high estimate of 20.00 and a low estimate of 13.00.

New Stock Coverage: Sun Shines on Hawaiian Holdings
Minyanville.com - May 18, 2012
By Justin Sharon May 18, 2012 9:25 am MINYANVILLE ORIGINAL Summoning 007 to ring the opening bell sure made it a banner day for "Bonds," with the subsequent rally in US Treasuries sending 10-year yields to their lowest close ever.

2012 Economic Outlook - Report Highlights Acorda Therapeutics Inc and ...
Business Review USA (press release) - May 18, 2012
HONG KONG--(Marketwire - May 17, 2012) - Today, www.BrightonMarkets.com announced new reports highlighting Acorda Therapeutics Inc ( NASDAQ : ACOR ) and Pharmacyclics, Inc. ( NASDAQ : PCYC ). Gain market insight with full analysis and research ...
Goldman Sachs Starts Acorda Therapeutics, Inc. (ACOR) at Sell - StreetInsider.com (subscription)

2012 Economic Outlook - Report Highlights Acorda Therapeutics Inc and ...
MarketWatch (press release) - May 17, 2012
HONG KONG, May 17, 2012 (MARKETWIRE via COMTEX) -- Today, www.BrightonMarkets.com announced new reports highlighting Acorda Therapeutics Inc (NASDAQ:ACOR) and Pharmacyclics, Inc. (NASDAQ:PCYC) .

Investing 101: Oversold Biotech Stocks
Kapitall Blog (blog) - May 16, 2012
Are you looking for biotech stocks that have been beaten up? Sometimes stocks can be so beaten and oversold that they trade below their fair value, which can be considered an opportunity to buy.

Revenues Climb at Acorda
Zacks.com - May 4, 2012
Acorda Therapeutics Inc. (ACOR - Snapshot Report) reported first quarter earnings (including share-based compensation charges) of 26 cents per share, compared to a loss of 2 cents in the year-ago period.

Acorda Therapeutics Reports First Quarter 2012 Financial Results
EON: Enhanced Online News (press release) - May 4, 2012
HAWTHORNE, NY--(EON: Enhanced Online News)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the first quarter ended March 31, 2012.

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>